Results 291 to 300 of about 202,195 (337)

Rare Presentation of Adult‐Onset Still's Disease Complicated by Acute Severe Hepatitis Refractory to Medical Treatment: A Case Report

open access: yesClinical Case Reports, Volume 13, Issue 7, July 2025.
ABSTRACT Managing adult‐onset Still's disease complicated by severe hepatitis requires vigilant monitoring and adaptable therapeutic strategies. Standard treatments such as tocilizumab and rituximab can cause adverse reactions or lose efficacy. The interplay of systemic inflammation and liver involvement highlights the need for ongoing research to find
Majed Ali   +3 more
wiley   +1 more source

Drug-Induced Renal Vasculitis: Etiology, Pathogenesis, Clinical Manifestations, and Therapeutic Approaches-A Narrative Review. [PDF]

open access: yesHealth Sci Rep
Mohamed Siraj H   +7 more
europepmc   +1 more source

Advanced imaging of relapse in giant cell arteritis: The role of vascular adhesion protein‐1 and [68Ga]Ga‐DOTA‐Siglec‐9 positron emission tomography–computed tomography

open access: yes
Journal of Internal Medicine, Volume 298, Issue 2, Page 138-142, August 2025.
Simon M. Petzinna   +13 more
wiley   +1 more source

Is there a role of genetics in acute and chronic urticaria—A systematic review and meta‐analysis

open access: yesClinical and Translational Allergy, Volume 15, Issue 7, July 2025.
Abstract Background Chronic urticaria (CU) is a heterogeneous skin disorder whose genetic drivers are incompletely defined. Objective To systematically review and meta‐analyse genetic and epigenetic factors that influence susceptibility and treatment response in acute and CU.
George N. Konstantinou   +2 more
wiley   +1 more source

Aggressive Head and Neck Squamous Cell Carcinoma in the Setting of GATA2 Deficiency

open access: yesHead &Neck, Volume 47, Issue 7, Page E82-E86, July 2025.
ABSTRACT Background GATA2 deficiency is a rare genetic disorder associated with hematologic, infectious, and neoplastic complications. We report a case of a patient with GATA2 deficiency who developed aggressive squamous cell carcinoma (SCC) of the head and neck, an atypical manifestation of this condition.
Brejjette Aljabi   +3 more
wiley   +1 more source

Indication‐Specific Dosing and Dose‐Evaluation Strategies in New Indications for Non‐Oncology Monoclonal Antibodies

open access: yesThe Journal of Clinical Pharmacology, Volume 65, Issue 7, Page 895-908, July 2025.
Abstract Compared to traditional small molecule drugs, monoclonal antibodies (mAbs) often display more complex pharmacokinetic (PK) and pharmacodynamic (PD) properties that may be impacted by disease‐specific factors. For mAbs in non‐oncology indications, where the same drug might be used for conditions involving different organ systems and/or having ...
Sherouk M. Tawfik, Fei Tang
wiley   +1 more source

Clinical Remission and Reduction of Circulating Nephritic Factors by Combining Rituximab With Belimumab in a Case of Complement Factor 3 Glomerulopathy

open access: yesKidney International Reports
Mieke van Schaik   +6 more
doaj  

Wound, pressure ulcer, and burn guidelines (2023)-4: Guidelines for the management of connective tissue disease/vasculitis-associated skin ulcers, third edition. [PDF]

open access: yesJ Dermatol
Asano Y   +27 more
europepmc   +1 more source

Asymptomatic hypertension and bilateral renal artery stenosis in Takayasu arteritis

open access: yes
ACR Open Rheumatology, Volume 7, Issue 7, July 2025.
Wan‐Hao Tsai, Chiao‐Feng Cheng
wiley   +1 more source

Urinary Complement Factor Ba: A New Tool for Early Detection of Acute Kidney Injury

open access: yesKidney International Reports
Daan P.C. van Doorn   +2 more
doaj  

Home - About - Disclaimer - Privacy